Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 25 trials
Active filters
Clinical trials found
Published and searchable clinical trials
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Hemolytic, +11 more
- Locations
-
- University of Maryland, Baltimore (UMB) Baltimore, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Haplo-Cord HSCT for AML/MDS
NCT07588360
- Conditions
- AML (Acute Myeloid Leukemia), Anemia, Anemia, Refractory, +11 more
- Locations
-
- Fujian Medical University Union Hospital Fuzhou, Fujian, China
- Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
- Sichuan Provincial People's Hospital Chengdu, Sichuan, China
- Chinese PLA General Hospital Beijing, China
NCT07607418
- Conditions
- AML (Acute Myeloid Leukemia), Anemia, Anemia, Refractory, +11 more
- Locations
-
- Ruijin Hospital Shanghai, Shanghai Municipality, China
NCT07500753
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +15 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT07400341
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Refractory, +8 more
- Locations
-
- The First Affiliated Hospital of Soochow University, Department of Hematology Suzhou, Jiangsu, China
NCT06839456
- Conditions
- Acquired Aplastic Anemia, Anemia, Anemia, Refractory, +35 more
- Locations
-
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
- Conditions
- AML (Acute Myeloid Leukemia), Anemia, Anemia, Refractory, +11 more
- Locations
-
- Oxford University Hospitals NHS Trust Oxford, OXFORDSHIRE, United Kingdom
Luspatercept + Darbepoetin in MDS
NCT07096297
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +5 more
- Locations
-
- Yale University New Haven, Connecticut, United States
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago, Illinois, United States
- Harold C. Simmons Comprehensive Cancer Center of UT Southwestern Dallas, Texas, United States
- Conditions
- AML (Acute Myelogenous Leukemia), Acute Leukemia (Category), Acute Lymphoid Leukemia (ALL), +36 more
- Locations
-
- University of Alabama Birmingham Birmingham, Alabama, United States
- City of Hope Duarte, California, United States
- Stanford Palo Alto, California, United States
- University of Miami Miami, Florida, United States
NCT07321626
- Conditions
- Acute Myeloid Leukemia, Anemia, Anemia, Refractory, +13 more
- Locations
-
- The First Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, China
NCT07347171
- Conditions
- AML, AML (Acute Myelogenous Leukemia), Anemia, +13 more
- Locations
-
- The First Affiliated Hospital of Nanchang University Nanchang, China
- The Haematology Hospital of the Chinese Academy of Medical Sciences Tianjin, China
- Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology Wuhan, China
NCT07297576
- Conditions
- ALL (Acute B-Lymphoblastic Leukemia), AML (Acute Myelogenous Leukemia, Anemia, +12 more
- Locations
-
- Institute of Hematology, Blood Diseases Hospital Tianjing, China
NCT06680752
- Conditions
- Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Anemia, +12 more
- Locations
-
- Novant Health Cancer Institute Charlotte, North Carolina, United States
- Novant Health Cancer Institute Winston-Salem, North Carolina, United States
- MD Anderson Cancer Center Houston, Texas, United States
Anti-NKG2A Monoclonal Antibody for AML or MDS Patients Undergoing Haploidentical Transplantation
NCT06892223
- Conditions
- Acute Myeloid Leukaemia, Anemia, Anemia, Refractory, +13 more
- Locations
-
- IRCCS Ospedale Policlinico San Martino Genova, GENOVA, Italy
- Irccs Istituto Clinico Humanitas Rozzano, MILANO, Italy
PRAISE-IR Versus CIBMTR Controls
NCT07717164
- Conditions
- ALL (Acute B-Lymphoblastic Leukemia), AML (Acute Myeloid Leukemia), Anemia, +12 more
- Locations
-
- Memorial Sloan Kettering Cancer center New York, United States
Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies
NCT07710781
- Conditions
- Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, +42 more
- Locations
-
Not specified
Forecasting Relapse Outcomes With AlloHeme-based Risk Detection in Post-Allo-HCT AML/MDS Patients (FORWARD)
NCT07607327
- Conditions
- AML (Acute Myelogenous Leukemia), Anemia, Anemia, Refractory, +16 more
- Locations
-
- CareDx, Inc. Brisbane, California, United States
Dresden MDS Registry With an Accompanying Biomaterial Collection
NCT07561385
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +8 more
- Locations
-
- Universitätsklinikum Carl Gustav Carus Dresden Dresden, Germany
A Long-term Follow-up Study of Patients With ARD103 CAR-T Cell Therapies
NCT06906380
- Conditions
- Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia, in Relapsed or Refractory, Anemia, +12 more
- Locations
-
- Novant Health Cancer Institute Charlotte, North Carolina, United States
- Novant Health Cancer Institute Winston-Salem, North Carolina, United States
- MD Anderson Cancer Center Houston, Texas, United States
Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning Before Allogeneic Stem Cell Transplantation
NCT07214064
- Conditions
- AML (Acute Myeloid Leukemia), Anemia, Anemia, Refractory, +12 more
- Locations
-
- University Hospital , Department of Internal Medicine II Tübingen, Baden-Wurttemberg, Germany